Our Science

Our Approach to
Ribosome targeted drugs

Leveraging TURBO-ZM, a highly efficient chemistry platform, we are generating novel, orally bioavailable small-molecule RMAs that:

  • Are functionally and structurally diverse
  • Can be readily optimized for disease specificity
  • Address substantial unmet needs